Quick technique to identify adenoviruses can improve patient careOctober 12, 2007NIAID media availability WHAT:Grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have adapted a rapid and accurate new molecular typing strategy and used it to conduct one of the most comprehensive studies of adenoviruses ever performed in the United States. Adenoviruses commonly cause respiratory illnesses and infections of the stomach, intestine, eyes and bladder. Sometimes they cause epidemics and deaths. The new findings, from the extensive adenovirus epidemiological data collected in the United States, reveal that adenoviruses are frequently associated with hospitalizations and that some of these viruses may cause more severe disease than others. The new gene sequencing strategy, first developed by researchers at the U.S. Centers for Disease Control and Prevention, identifies the adenovirus type in two days compared with the previous method that took weeks. The methodˇ-s speed will help public health officials better understand adenovirus outbreaks in communities and other settings where people are in close contact, such as hospitals and long-term care facilities. It also will help clinicians know what type is causing the infection in order to use the appropriate antiviral treatment. Some adenovirus strains, particularly those considered as emerging pathogens, are more often associated with severe disease and death.
In an effort to better understand how adenovirus infection is caused and spread in different settings and populations, Gregory Gray, M.D., of the University of Iowa, and his colleagues analyzed clinical adenovirus-positive samples and patient data from 22 military and civilian medical facilities over a 25-month period. They characterized the strains of 2,237 adenovirus-positive specimens and compared their sequences with those of the 51 recognized strains that infect humans. Highlights of their findings include the following: * The distribution of adenovirus types varies by patient age, disease state, and geographical location. * Adenovirus type 21 infections, which may cause more disease, have become more common. * Fifty percent of the clinical adenovirus isolates among civilians were associated with hospitalization, about 20 percent with a chronic disease condition, 11 percent with bone marrow or solid organ transplantation, and 4 percent with a cancer diagnosis. * Children under seven years of age, people with an underlying chronic disease, and those with recent organ transplantation are at greater risk of adenovirus infection and disease. * A relatively high number of transplantation patients were found to have infections with multiple adenovirus isolates over time. Researchers say quickly recognizing the adenovirus type is key to starting the appropriate antiviral therapy, controlling outbreaks and understanding the association of adenoviruses with a number of chronic disease conditions. Dr. Gray and his colleagues are using the molecular typing technique to help clinicians do just that. NIH/National Institute of Allergy and Infectious Diseases | |||||||||||||||||||||
|
Related Adenovirus Current Events and Adenovirus News Articles Results of landmark study of HIV vaccine published in the Lancet Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV vaccine. T cell-based HIV vaccine candidate demonstrates positive results The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520. How HIV vaccine might have increased odds of infection In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection. New mechanism for cardiac arrhythmia discovered It has long been thought that virus infections can cause cardiac arrhythmia. But why has not been understood. Ulrike Lisewski, Dr. Yu Shi, Michael Radke and Professor Michael Gotthardt of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now discovered the molecular mechanism. UAB Anti-Cancer Research Featured in Scientific American Scientific American magazine focused on two University of Alabama at Birmingham (UAB) Comprehensive Cancer Center researchers in a news story on experimental next-generation anti-cancer therapies. Joslin study identifies protein that produces 'good' fat A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity. Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease. Gene therapy increases survival for end-stage head and neck cancer A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. New vaccine may give long-term defense against deadly bird flu and its variant forms A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice. In blood vessel stents, innovative materials allow better control, delivery of gene therapy Before gene therapy becomes practical for treating human diseases, researchers must master the details of safe and effective delivery. More Adenovirus Current Events and Adenovirus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||